Monday, June 22, 2026
🇺🇸 FDA

Patent directory · USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,771
Drugs linked 4,798

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 522 of 1,261

  1. US 10182984

    Targeted interferons demonstrate potent apoptotic and anti-tumor activities

    The Regents of the University of California · Granted Jan 22, 2019 · Expires Jan 17, 2039

    granted

  2. US 10182988

    Liposomal particles, methods of making same and uses thereof

    Northwestern University · Granted Jan 22, 2019 · Expires Jan 17, 2039

    granted

  3. US 10182994

    Nanoparticulate complex of nicotine and cerium oxide and use thereof

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Jan 22, 2019 · Expires Jan 17, 2039

    granted

  4. US 10182997

    Liposomal curcumin for treatment of cancer

    The Board of Regents of the University of Texas System · Granted Jan 22, 2019 · Expires Jan 17, 2039

    granted

  5. US 10184004

    CD47 targeted therapies for the treatment of infectious disease

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Jan 22, 2019 · Expires Jan 17, 2039

    granted

  6. US 10184931

    Methods and systems for measuring and using the oxidation-reduction potential of a biological sample

    Aytu BioScience, Inc. · Granted Jan 22, 2019 · Expires Jan 17, 2039

    granted

  7. US 10184124

    RNA interference in ocular indications

    Phio Pharmaceuticals Corp. · Granted Jan 22, 2019 · Expires Jan 17, 2039

    granted

  8. US 10184125

    Modulation of TMPRSS6 expression

    Ionis Pharmaceuticals, Inc. · Granted Jan 22, 2019 · Expires Jan 17, 2039

    granted

  9. US 10183972

    BK channel-modulating peptides and their use

    The Board of Regents of the University of Texas System · Granted Jan 22, 2019 · Expires Jan 17, 2039

    granted

  10. US 10183933

    Isoindolinone inhibitors of phosphatidylinositol 3-kinase

    Vertex Pharmaceuticals Incorporated · Granted Jan 22, 2019 · Expires Jan 17, 2039

    granted

  11. US 10183927

    Crystalline forms of C21H22Cl2N4O2

    Vertex Pharmaceuticals Incorporated · Granted Jan 22, 2019 · Expires Jan 17, 2039

    granted

  12. US 10183936

    Hepatitis B core protein allosteric modulators

    ASSEMBLY BIOSCIENCES, INC. · Granted Jan 22, 2019 · Expires Jan 17, 2039

    granted

  13. US 10183915

    Axially chiral isomers, and preparation methods therefor and pharmaceutical uses thereof

    Medshine Discovery Inc. · Granted Jan 22, 2019 · Expires Jan 17, 2039

    granted

  14. US 10183055

    Ang-(1-7) derivative oligopeptides for the treatment of pain and other indications

    Arizona Board of Regents on Behalf of the University of Arizona · Granted Jan 22, 2019 · Expires Jan 17, 2039

    granted

  15. US 10179919

    Multigenome retroviral vector preparations and methods and systems for producing and using same

    IMMUNE DESIGN CORP. · Granted Jan 15, 2019 · Expires Jan 10, 2039

    granted

  16. US 10179912

    RNA modulating oligonucleotides with improved characteristics for the treatment of duchenne and becker muscular dystrophy

    BIOMARIN TECHNOLOGIES B.V. · Granted Jan 15, 2019 · Expires Jan 10, 2039

    granted

  17. US 10179817

    Anti-CD71 antibodies, activatable anti-CD71 antibodies, and methods of use thereof

    CytomX Therapeutics, Inc. · Granted Jan 15, 2019 · Expires Jan 10, 2039

    granted

  18. US 10179187

    Bioresorbable embolization microspheres

    Regents of the University of Minnesota · Granted Jan 15, 2019 · Expires Jan 10, 2039

    granted

  19. US 10179767

    Substituted benzamides and methods of use thereof

    Xenon Pharmaceuticals Inc. · Granted Jan 15, 2019 · Expires Jan 10, 2039

    granted

  20. US 10179168

    HPV particles and uses thereof

    Aura Biosciences, Inc. · Granted Jan 15, 2019 · Expires Jan 10, 2039

    granted

  21. US 10179228

    Swallowable drug delivery device and methods of drug delivery

    Rani Therapeutics, LLC · Granted Jan 15, 2019 · Expires Jan 10, 2039

    granted

  22. US 10179151

    Methods of transdifferentiation and methods of use thereof

    TEL HASHOMER MEDICAL RESEARCH INFRASTRUCTURE AND SERVICES LTD. · Granted Jan 15, 2019 · Expires Jan 10, 2039

    granted

  23. US 10179142

    Treatment and/or prevention of bone metastasis

    Arizona Board of Regents on Behalf of the University of Arizona · Granted Jan 15, 2019 · Expires Jan 10, 2039

    granted

  24. US 10179131

    Hepatitis B antiviral agents

    Enanta Pharmaceuticals, Inc. · Granted Jan 15, 2019 · Expires Jan 10, 2039

    granted

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.